Politics Sarah Owermohle STAT Plus: Biden appoints former government scientist as first leader of ARPA-H
In the Lab Theresa Gaffney Unprecedented! Incredible! Scientific grant applications are getting heavier on hype
D.C. Diagnosis Edward Chen A chaotic sprint to lower insulin prices and AIDS activists go after Biden on monkeypox
Politics Lev Facher STAT Plus: Cities are lobbying to host the ARPA-H headquarters. Experts don’t understand why
Exclusive Lev Facher STAT Plus: In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans
Politics Lev Facher STAT Plus: Congress is closer than ever to formally authorizing ARPA-H. But the details aren’t as final as they seem
Politics Lev Facher STAT Plus: Francis Collins: Concern about independence of new moonshot science agency ARPA-H are ‘overblown’
Politics Lev Facher STAT Plus: The panel was supposed to improve efficiency at the NIH. It hasn’t even met for 7 years
Politics Lev Facher STAT Plus: A new nonprofit wants to rewrite the playbook for how the U.S. government funds science
Politics Nicholas Florko STAT Plus: CDC, FDA, and NIH staffers aren’t reporting political interference, new watchdog report shows
Politics Lev Facher STAT Plus: Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on
Exclusive Lev Facher STAT Plus: Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence
Politics Lev Facher STAT Plus: Lander: New cancer plan ‘more ambitious by far’ than original moonshot
Pharmalot Ed Silverman STAT Plus: Facing intense criticism, Moderna pauses bitter dispute with the NIH over Covid-19 vaccine patents
Politics Lev Facher NIH’s Francis Collins: For Biden’s new research agency to succeed, it should prepare for some projects to fail
Health Kate Sheridan Ginkgo Bioworks, Mammoth Biosciences among winners of NIH’s ‘Shark Tank’ for Covid-19 tests
First Opinion Jennifer Spotila The NIH is thwarting research on a poorly understood yet serious condition
Exclusive Sharon Begley and Andrew Joseph STAT Plus: New alcohol-advertising research stopped with NIH branch director’s arrival
Exclusive Sharon Begley STAT Plus: NIH rejected a study of alcohol advertising while pursuing industry funding for other research